Cargando…
Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients
Rectal cancer constitutes approximately one-third of all colorectal cancers and contributes to considerable mortality globally. In contrast to colon cancer, the standard treatment for localized rectal cancer often involves neoadjuvant chemoradiotherapy. Tumour response rates to treatment show substa...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317379/ https://www.ncbi.nlm.nih.gov/pubmed/34321074 http://dx.doi.org/10.1186/s40364-021-00313-9 |